Биология ва тиббиёт муаммолари 2025, №4 (163)

Maqola mavzusi

ПОДАГРА БИЛАН КАСАЛЛАНГАН БЕМОРЛАРНИНГ БУЙРАК ҲОЛАТИНИ БАҲОЛАШ (251-256)

Mualliflar

Шодикулова Гуландом Зикрияевна, Каримов Азизжон Хамрақулович, Пулатов Улуғбек Сунатович

Muassasa

Самарқанд давлат тиббиёт университети, Ўзбекистон Республикаси, Самарқанд ш.

Annotatsiya

Ушбу тадқиқотда подагра билан касалланган беморларда буйрак функцияси ва клиник ҳолати баҳоланди. Беморлар 3 гуруҳга ажратилди: ички аъзолари шикастланмаганлар, жигар ва буйраги шикастланганлар ҳамда фақат буйраги шикастланганлар. Биокимёвий ва лаборатор кўрсаткичлар, УТТ ва умумий сийдик таҳлили натижалари асосида подагра касаллигининг коморбид ҳолатларга, хусусан, нефропатияга таъсири таҳлил қилинди. Артериал гипертония, уратурия, протеинурия, сийдик тош касалликлари, лейкоцитурия ва гематурия ҳолатлари юқори учраш частотасида қайд этилди. Текширув натижалари гиперурикемияга қарши гипоурикемик терапия ва турмуш тарзини ўзгартириш зарурлигини кўрсатади.

Kalit so'zlar

подагра, буйрак функцияси, нефропатия, гиперурикемия, протеинурия, уратурия, артрит, лаборатор кўрсаткичлар, УТТ, коморбид ҳолатлар.

Adabiyotlar

1. Abhishek A, Valdes AM, Jenkins W, Zhang W, Doherty M. Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study. PLoS One. 2017 Oct 12;12(10):e0186096. doi: 10.1371/journal.pone.0186096. PMID: 29023487; PMCID: PMC5638318. 2. Adashek ML, Bourji KI. Pegloticase Induced Hemolytic Anemia in a Patient With G6PD Deficiency. J Hematol. 2018 May;7(2):83-85. doi: 10.14740/jh402w. Epub 2018 May 10. PMID: 32300419; PMCID: PMC7155862. 3. Alimdjanovich R. J., Rubenovna A. I., Abduvokhidovna I. Y. Specialized center for the patients with chronic heart failure-extension of life // Вопросы науки и образования. – 2021. – №. 22 (147). – С. 14-24. 4. Alrajeh, K.Y.; Roman, Y.M. Pharmacogenetic Perspective for Optimal Gout Management. Future Pharmacol. 2022, 2, 135-152. https://doi.org/10.3390/futurepharmacol2020011 5. Amatucci AJ, Padnick-Silver L, LaMoreaux B, Bulbin DH. Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatol Ther. 2023 Aug;10(4):809-823. doi: 10.1007/s40744-023-00565-x. Epub 2023 Jun 19. PMID: 37335432; PMCID: PMC10326179. 6. Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, Synold T, Burckart GJ, Rao PA, Shapiro B, Gill M. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. Pharmacotherapy. 2008 Jul;28(7):883-94. doi: 10.1592/phco.28.7.883. PMID: 18576903.. 7. Bezalel Y, Gershoni-Baruch R, Dagan E, Lidar M, Livneh A. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever. Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S103-4. PMID: 19796545. 8. Borić-Bilušić AA, Božina N, Lalić Z, Lovrić M, Nađ-Škegro S, Penezić L, Barišić K, Trkulja V. Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study. Adv Ther. 2023 Feb;40(2):601-618. doi: 10.1007/s12325-022-02378-w. Epub 2022 Nov 25. PMID: 36434147. 9. Bortolotti M, Polito L, Battelli MG, Bolognesi A. Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol. 2021 May;41:101882. doi: 10.1016/j.redox.2021.101882. Epub 2021 Jan 27. PMID: 33578127; PMCID: PMC7879036. 10. Bowden RG, Richardson KA, Richardson LT. Uric acid and metabolic syndrome: Findings from national health and nutrition examination survey. Front Med (Lausanne). 2022 Dec 14;9:1039230. doi: 10.3389/fmed.2022.1039230. PMID: 36590930; PMCID: PMC9795410. 11. Rizayev J. A., Agababyan I. R., Ismoilova Yu A. Медицинские науки specialized center for the patients with // Вопросы науки и образования. – С. 14. 12. Rizaev J. A., Nazarova N. S., Vohidov E. R. Homilador ayollarda parodont kasalliklari rivojlanishining patogenetik jihatlari // Журнал гуманитарных и естественных наук. – 2024. – №. 11 [2]. – С. 104-107. 13. Rizaev J. A., ugli Sattorov B. B., Nazarova N. S. Analysis of the scientific basis for organizing dental care for workers in contact with epoxy resin // Журнал гуманитарных и естественных наук. – 2024. – №. 15. – С. 280-283. 14. Rizaev J. A., Rizaev E. A., Akhmadaliev N. N. Current View of the Problem: A New Approach to Covid-19 Treatment // Indian Journal of Forensic Medicine & Toxicology. – 2020. – Т. 14. – №. 4. 15. Card-Gowers J, Retat L, Kumar A, Marder BA, Padnick-Silver L, LaMoreaux B, Webber L. Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatol Ther. 2024 Aug;11(4):913-926. doi: 10.1007/s40744-024-00681-2. Epub 2024 Jun 5. PMID: 38836994; PMCID: PMC11264668. 16. Carroll MB, Smith DM, Shaak TL. Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose. Rheumatol Int. 2017 Mar;37(3):445-453. doi: 10.1007/s00296-016-3592-2. Epub 2016 Oct 31. PMID: 27798726. 17. Cho C, Kim B, Kim DS, Hwang MY, Shim I, Song M, Lee YC, Jung SH, Cho SK, Park WY, Myung W, Kim BJ, Do R, Choi HK, Merriman TR, Kim YJ, Won HH. Large-scale cross-ancestry genome-wide meta-analysis of serum urate. Nat Commun. 2024 Apr 24;15(1):3441. 18. Choi HG, Kwon BC, Kwon MJ, Kim JH, Kim JH, Park B, Lee JW. Association between Gout and Dyslipidemia: A Nested Case-Control Study Using a National Health Screening Cohort. J Pers Med. 2022 Apr 8;12(4):605. doi: 10.3390/jpm12040605. PMID: 35455721; PMCID: PMC9032264. 19. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22;388(10055):2039-2052. 20. Dean L, Kane M. Pegloticase Therapy and G6PD Genotype. 2020 Oct 1. In: Pratt VM, Scott SA, Pirmohamed M, et al., editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012.